by European Public Health Alliance | May 31, 2019 | Opinion
Gabriel Siles-Brügge, Associate Professor in Public Policy at the University of Warwick & EPHA Scientific Advisor on Trade Policy Significant concerns have been raised regarding the risks posed by investor-to-state dispute settlement (ISDS) for tobacco regulation....
by European Public Health Alliance | May 28, 2019 | Statements
By Susanne Løgstrup, Director, European Heart Network; Former Member of the European Commission Transatlantic Trade and Investment Agreement (TTIP) advisory group At the heart of international trade is the belief that it will have a positive economic benefit....
by European Public Health Alliance | May 3, 2019 | Opinion
As trade and investment agreements increasingly focus on “non-tariff barriers” their potential impacts on public health increase. Trade agreements can affect many issues including their impact on antimicrobial resistance which is often overlooked. Unhealthy Trade?...
by European Public Health Alliance | May 2, 2019 | Uncategorized
Medicines and medical devices, antimicrobial resistance and digital health in EU-U.S. regulatory cooperation activities Following the agreement on July 2018 between European Commission President Jean-Claude Juncker and US President Donald Trump to launch a new phase...
by European Public Health Alliance | Sep 27, 2018 | Statements
Trade, investment and public health An EPHA guide and risk assessment tool This document is intended for public health professionals, as an introduction to trade and investment policy and its relevance to public health. It also offers a tool for public health...
